Cedric Steiner, a nursing home administrator, talks about how crucial proper ventilation is in reducing infection, not only in nursing homes but in all buildings. He also outlines some best approaches to this problem. If you work indoors—and that’s most of us—you’ll want to pay attention.
3D printing technology is already revolutionizing some health care fields while the technology’s full potential has yet to be realized. We spoke with Michael Jafar, president and CEO of 3D printing company Desktop Health, to learn more about this emerging technology. Jafar shares where he thinks the technology is poised to make a big impact on patient care and treatment outcomes, as well as why the dental industry has so quickly embraced this technology, and the hurdles still to be cleared before this technology is ready for even wider use in health care settings.
James Beckman, MD, is the creator of a topical application that stops the progression of a first or second degree burn and reverse the symptoms already present as soon as possible after the burn. We discuss the science behind this burn reversal method, the complexities of working with burned skin, and what needs to be considered when working with a burned patient.
Drug pricing can be overwhelming—even for the well-informed—but companies like SingleCare are striving to help patients afford their medications. Ramzi Yacoub, PharmD, Chief Pharmacy Officer at SingleCare, sat down with Drug Topics® to discuss the ins and outs of medication discount cards and coupons.
Monoclonal antibodies have become a beacon of hope for patients at high risk of COVID-19 who may not have a full response to the vaccines, or for whom vaccination isn’t an option. In an interview with Pharmacy Times, Alfred L’Altrelli, senior director of pharmacy at UPMC Presbyterian-Shadyside, discussed how pharmacists are ensuring patient access to these important treatments.
What can we do to advance psychoanalytic thought? In this installment of Deep Dive, Heidi Anne Duerr, MPH, associate editorial director of Psychiatric Times, interviews William A. Myerson, PhD, MBA, of the Sigourney Awards and the Center for Psychoanalytic Studies, about the latest Sigourney Award recipients and how the Sigourney Award is enhancing psychoanalytic thought worldwide.
Damien Berg, BA, BS, CRCST, AAMIF, vice president of strategic initiatives for the Healthcare Sterile Processing Association (HSPA, formerly IAHCSMM), previews the upcoming annual meeting and offers a behind-the-scenes look into the critical work of sterile processing professionals within the healthcare system.
In this segment, Practical Cardiology sits down with Dr. Ziyad Al-Aly to discuss a recent study he led examining long-term cardiovascular outcomes among patients with COVID-19. An analysis with data from more than 10 million patients, Al-Aly’s work provide insight into the immediate risk of negative cardiovascular outcomes associated with COVID, but also shed light on long-term effects and the impact of COVID-19 severity on this apparent increase in risk for negative outcomes.
As we begin to emerge from the shadows of the COVID-19 pandemic, it is clear that radiologists, particularly breast radiologists, are faced with significant challenges. On top of workload issues, they may be communicating a greater number of advanced breast cancer diagnoses due to pandemic-related screening delays. However, as Amy K. Patel, MD, points out, there are also emerging opportunities to save lives.
Dr. Andrew Schuman provides tips and guidance for using the evaluation and management coding system from CMS.
Charcot-Marie-Tooth (CMT) may be the most common condition involving the peripheral nervous system. However, it's estimated that only 150,000 Americans and 3 million people across the globe live with it, making it a rare disease. In an interview with Giuliana Grossi, Associate Editor, HCPLive, Dr. Keith Fargo discusses some of the challenges in the field and addresses the importance of being cognizant of the blood-nerve barrier when treating patients and developing therapies for CMT.
In this episode of Deep Dive, Peter Wehrwein, managing editor of Managed Healthcare Executive, speaks with Mark Nolan, chief operating officer of Hint Health. Hint Health is a company in the business of supporting primary care direct contracting. Direct contracting cuts out insurance companies. Instead of accepting insurance payment, practices are paid a flat fee. Wehrwein and Nolan discuss how direct primary care differs from concierge care and how CMS’ value-based payment models and ACOs fit with what Hint is doing.
Women physicians today are suffering from record-breaking levels of burnout. Tammie Chang, MD, was one of those women. When she began to feel dangerously burnt out, she decided to write a self-help book for women struggling to balance their personal and professional lives. Tammie writes for these women in hopes that they can become empowered and learn to set healthy boundaries in their daily lives.
In recognition of Black History Month, Ozuru O. Ukoha, MD, highlights barriers that may hinder participation of Black patients in clinical lung cancer research, how these disparities impact outcomes, and how initiatives such as the American Lung Association’s Awareness, Trust and Action campaign may work to increase enrollment. He not only discusses short-and long-term goals of the campaign, but what the oncology community as a whole can do to be more inclusive of diverse patient populations.
Findings of a recent Health Affairs study showed that race and bias were significantly associated with negative patient descriptors in the electronic health record. On today’s Deep Dive, Michael Sun, first author of the study and a medical student at the Pritzker School of Medicine at the University of Chicago, discusses the impact of potentially stigmatizing language on racial and ethnic health care disparities and building awareness among clinicians.
Lori Pierce, MD, highlights reasons for the need of increased diversity within the oncology field.
On this episode of Deep Dive, Dr Cynthia Otto sits down with dvm360 to discuss the life of a detection dog at the University of Pennsylvania’s Working Dog Center and explains how they train these dogs to smell anything from explosive devices to COVID-19.
Dr. Kathleen B. Digre focuses on opportunities for women leaders in the field of neurology. We spoke at length about her past and present leadership roles, and she shared her perspective on how the field has changed and provided more opportunity for females in the space.
Sarah Temkin, Associate Director for Clinical Research in the Office of Research on Women’s Health at the National Institutes of Health, discusses how the NIH Office of Research on Women’s Health are involved in health care and pharmacy practice. She talks about clinical data pertaining to biological and sociological variables and clinical trials that have been conducted. Additionally, she addresses the upcoming goals and projects on the horizon for the NIH ORWH that may impact the pharmacy field.
Oncology Nursing News® meets with the lead investigator of a study which revealed that children under 5 are at the highest risk of hearing loss following treatment with cisplatin chemotherapy. Dr. Bruce Carleton discusses the benefits and risks associated with this life-saving therapy, and the challenge of balancing these risks when treating young children with cancer.
Christine Dehlendorf, MD, MAS, is passionate about returning women to the center of decisions made about contraception and family planning. To some the term “patient centered counseling” may sound overused, even gimmicky. But when the topic is how, when, or if a woman wants to conceive, the first job of the clinician is to elicit the patient’s needs and desires as the patient defines them, not to forge ahead based on a preconceived notion of what “a patient like this” should want or should do. Her research focuses on how to facilitate this shift of choice fully back into the patient’s hands.
CAR-T cell therapy has dramatically changed the game for many cancer types. Recent findings in a trial examining a second-line CAR-T therapy option for large B-cell lymphoma showed a potential to shift the standard of care. In an interview with CURE®, Joseph McGuirk, D.O., discussed the inspiring ways in which CAR-T therapy advancements are transforming the cancer landscape.
Dr. Jean Talleyrand, Co-Founder and Vice-Chairman of the Clinical Endocannabinoid System Consortium (CESC) and founder of MediCann, joins us to discuss medical cannabis research and ongoing projects he is involved in. As a third generation medical provider, Dr. Talleyrand offers his insight into how medical cannabis can be added as a tool for any doctor to consider.
Anders Gilberg, senior vice president for government affairs at MGMA, joined Deep Dive to discuss what can be expected this year in terms of healthcare policy.
Ahead of a presentation during the 18th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®, Dr. Michael of Memorial Sloan Kettering Cancer Center discusses recent advances in treatment for patients with metastatic melanoma.
Geolani Dy, MD, and Gaines Blasdel discuss what urologists can do to help transgender patients and how this role will evolve over time. Dy is an Assistant Professor of Urology and Plastic and Reconstructive Surgery at Oregon Health & Science University in Portland, Oregon, who specializes in gender-affirming surgery within the OHSU Transgender Health Program. She also led the creation of Transgender and Non-Binary Surgery Allied Research Collective (TRANS-ARC), which focuses on patient-centered outcomes of genital gender-affirming surgery. Blasdel is a transgender man and gender affirming surgery outcomes researcher at NYU Langone Health in New York City, New York. He is also a TRANS-ARC Steering Committee Member.
Arjun Srinivasan, MD, is the Associate Director for Healthcare Associated Prevention Programs, Division of Healthcare Quality Promotion at the Centers for Disease Control and Prevention. One of Doctor Srinivasan’s concerns is the growing threat posed by pathogens that are becoming immune to antibiotics. In the interview, he talks about ways the government might try to encourage pharmaceutical companies to develop new, more effective antibiotics.
Drug development via a pathway approach creates the potential to treat multiple diseases with a single therapy. Alyssa Johnsen, MD, PhD, joins Deep Dive to discuss how the ongoing research by Janssen Immunology continues to confirm their IL-pathway model to treating immune mediated diseases.
Dr. Rexford Ahima discusses pediatric obesity in the United States and how the pandemic has affected it.
Dr. Keipp Talbot discussed with us the currently increasing rate of influenza in the US, as well as the state of research into flu vaccination—a topic which has significant scrutiny right now given the efficacy of COVID-19 vaccines. Among those options for advancing flu vaccines were products designed for older and/or immunocompromised patients, as well as mRNA technology. Additionally, she discussed how, contrary to common belief, flu research may be better informed by sequencing and screening strategies implemented by COVID-19 response—not the other way around.
